Malaria Diagnostics Market

Malaria is a disease caused by plasmodium parasite, transmitted by bite of infected mosquitoes. When it bites, the mosquito injects malaria parasites into the blood. The severity of malaria varies based on the species of plasmodium. The majority of victims are young children from sub-Saharan Africa. The gold standard for the diagnosis of malaria involves microscopy with visualization of Giemsa-stained parasites in a blood sample. Malaria parasites can be identified by examining under the microscope a drop of the patient's blood. WHO recommends prompt parasite-based diagnosis by microscopy or malaria rapid diagnostic test (RDT) in all patients suspected of malaria before antimalarial treatment is administered. Market Dynamics Increasing incidence of malaria, growing demand for novel diagnostic tools in malaria-endemic regions, and increasing government initiatives for prevention of malaria are some major factors expected to aid in the growth of the global malaria diagnostics market over the forecast period. For instance, according to the Ministry of Health and Family Welfare (Government of India), India is the only high endemic country which has reported a decline of 17.6% in 2019 compared to 2018. Moreover, the Government of India has developed a National Framework for Malaria Elimination (2016-2030) and a National Strategic Plan (2017-2022) with the aim to eliminate malaria (zero indigenous cases) in all Category 1 and 2 districts by 2022. Key features of the study • This report provides in-depth analysis of the global malaria diagnostics market, and provides market size (USD Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year. • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market. • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players. • It profiles key players in the global malaria diagnostics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies. • Key companies covered as a part of this study include Siemens Healthineers, Nikon Corporation, Bio-Rad Laboratories Inc., BioMérieux, Abbott Laboratories, Access Bio, Thermo Fisher Scientific Inc., Meril Life Sciences Pvt Ltd., and Premier Medical Corporation Pvt Ltd., among others. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics. • The global malaria diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts. • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global malaria diagnostics market. Market Segmentation • By Technology Insights (Revenue, USD Mn, 2020 - 2033) o Microscopy o Rapid Diagnostic Tests o Molecular Diagnostic Tests o Other Technologies • By Region Insights (Revenue, USD Mn, 2020 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East & Africa  GCC Countries  Israel  Rest of Middle East & Africa • Key Players o Bio-Rad Laboratories Inc. o Nikon Corporation o Siemens Healthineers o BioMérieux o Abbott Laboratories o Access Bio o Thermo Fisher Scientific Inc. o Meril Life Sciences Pvt Ltd. o Premier Medical Corporation Pvt Ltd. o Others